National Justice for Animals Week is an annual event dedicated to raising public awareness around crimes committed against animals and will take place February 20-26, 2022. Student chapters are encouraged to get involved for a week of action!
Join us for a special National Justice for Animals Week event on “Defining Justice.” This pre-recorded event will launch on February 21, 2022 and features Animal Legal Defense Fund Managing Attorney, Emily Lewis, and Legislative Affairs Manager, Brian Hackett, as they detail what justice means for animal victims.
Topics include information on the Courtroom Animal Advocacy Programs, the involvement of veterinarians in cruelty investigations, mental health and alternative sentencing assessments, possession bans, and more! Student chapters are encouraged to host a viewing party and discussion questions will be made available.
Watch the recorded webinar:
Resources
- How We Work: Criminal Justice
- National Justice for Animals Week
- Collaborative Response Project
- How We Work: Legislation
- Legislation – State Bills
- Courtroom Animal Advocate Programs (CAAP)
- Possession Bans: A Model Law
- 2021 U.S. State Animal Protection Laws Rankings
- National Justice for Animals Week: Defining Justice – Discussion Questions (PDF)
- National Justice for Animals Week: Defining Justice – PPT Presentation (PDF)
-
Emily Lewis
Managing Attorney
Focus Area
How We Work
Related
-
Animal Legal Defense Fund Grant Supported Washington Attorney General’s Enforcement of Animal Cruelty Law
The judge sentenced a Snohomish County resident for killing then displaying neighborhood wildlife and shooting a kitten in the eye.April 18, 2024 News -
REPORT: 95 Percent of Consumers Prefer “Climate-Friendly” Products, But Labels Oversell Emission Reductions
New report reveals how misleading labels lead to increased confusion among consumers searching for more sustainable, less environmentally damaging products.April 2, 2024 Press Release -
Lawsuit Filed Demanding FDA Respond to Petitions Seeking to Ban Ractopamine
FDA’s approval for ractopamine relied primarily on safety studies conducted by the drugmaker.March 26, 2024 Press Release